DEANNA HOPKINS: Open Payments
NPI 1972029783 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 13 payments from 12 companies in 2025. Trend: 2023 $1,039 · 2024 $60 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $82 |
| Eisai Inc. | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
Products named: Enhertu, WAINUA, Lenvima, ULTOMIRIS, Trodelvy, TALVEY, SCEMBLIX, GILOTRIF.
Industry payments across TN — which companies pay providers there.
